{"AllianceGenome": "7745", "HGNC": "7745", "MIM": "604043", "_id": "4751", "_version": 3, "accession": {"genomic": ["AC096637.1", "AL356310.5", "CH471100.2", "CP068277.2", "KT584499.1", "NC_000001.11", "NC_060925.1", "NG_029112.1"], "protein": ["AAA19558.1", "AAH43502.2", "AAH52807.1", "AAH65932.1", "AAK92212.1", "AAV38534.1", "AAW56418.1", "BAD97073.1", "BAG64202.1", "CAA80912.1", "CAA82309.1", "EAW93410.1", "EAW93411.1", "NP_001191111.1", "NP_001191112.1", "NP_002488.1", "P51955.1"], "rna": ["AK223353.1", "AK225522.1", "AK303092.1", "AY045701.1", "AY863109.1", "BC043502.1", "BC052807.1", "BC065932.1", "BT019729.1", "BU517064.1", "DC407297.1", "DQ786247.1", "DQ786281.1", "NM_001204182.2", "NM_001204183.2", "NM_002497.4", "U11050.1", "Z25425.1", "Z29066.1"], "translation": [{"protein": "AAV38534.1", "rna": "BT019729.1"}, {"protein": "AAH52807.1", "rna": "BC052807.1"}, {"protein": "AAH43502.2", "rna": "BC043502.1"}, {"protein": "BAG64202.1", "rna": "AK303092.1"}, {"protein": "AAK92212.1", "rna": "AY045701.1"}, {"protein": "CAA80912.1", "rna": "Z25425.1"}, {"protein": "NP_001191111.1", "rna": "NM_001204182.2"}, {"protein": "BAD97073.1", "rna": "AK223353.1"}, {"protein": "AAA19558.1", "rna": "U11050.1"}, {"protein": "AAH65932.1", "rna": "BC065932.1"}, {"protein": "NP_001191112.1", "rna": "NM_001204183.2"}, {"protein": "AAW56418.1", "rna": "AY863109.1"}, {"protein": "NP_002488.1", "rna": "NM_002497.4"}, {"protein": "CAA82309.1", "rna": "Z29066.1"}]}, "alias": ["HsPK21", "NEK2A", "NLK1", "PPP1R111", "RP67"], "ec": "2.7.11.1", "ensembl": {"gene": "ENSG00000117650", "protein": ["ENSP00000355965", "ENSP00000355966", "ENSP00000440237"], "transcript": ["ENST00000366998", "ENST00000366999", "ENST00000462283", "ENST00000489633", "ENST00000540251"], "translation": [{"protein": "ENSP00000355966", "rna": "ENST00000366999"}, {"protein": "ENSP00000355965", "rna": "ENST00000366998"}, {"protein": "ENSP00000440237", "rna": "ENST00000540251"}], "type_of_gene": "protein_coding"}, "entrezgene": "4751", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 21.5202777197, "exp_mis": 150.558444595, "exp_syn": 55.7489140072, "lof_z": 1.81936356604624, "mis_z": 1.29785755859273, "mu_lof": 1.61772279632e-06, "mu_mis": 1.32131625346e-05, "mu_syn": 4.71191735179e-06, "n_lof": 13.0, "n_mis": 118.0, "n_syn": 59.0, "p_li": 8.72367756771365e-07, "p_null": 0.0829956973318805, "p_rec": 0.917003430300363, "syn_z": -0.269935663746794}, "bp": 1338, "cds_end": 211848821, "cds_start": 211836767, "n_exons": 8, "nonpsych": {"exp_lof": 19.3151625607, "exp_mis": 136.107159196, "exp_syn": 50.295379163, "lof_z": 1.63465737420407, "mis_z": 1.82044493067881, "mu_lof": 1.61772279632e-06, "mu_mis": 1.32131625346e-05, "mu_syn": 4.71191735179e-06, "n_lof": 12.0, "n_mis": 94.0, "n_syn": 53.0, "p_li": 2.18450689647747e-06, "p_null": 0.120828320588137, "p_rec": 0.879169494904966, "syn_z": -0.240107501462804}, "nontcga": {"exp_lof": 19.7827910844, "exp_mis": 138.497913689, "exp_syn": 51.2731355453, "lof_z": 1.72612741486126, "mis_z": 1.29109541752868, "mu_lof": 1.61772279632e-06, "mu_mis": 1.32131625346e-05, "mu_syn": 4.71191735179e-06, "n_lof": 12.0, "n_mis": 108.0, "n_syn": 50.0, "p_li": 2.44627286064236e-06, "p_null": 0.0911353444521478, "p_rec": 0.908862209274992, "syn_z": 0.112577993953891}, "transcript": "ENST00000366999.4"}, "exons": [{"cdsend": 211675479, "cdsstart": 211658656, "chr": "1", "position": [[211658256, 211658712], [211667105, 211667231], [211669112, 211669332], [211670280, 211670407], [211671201, 211671284], [211673482, 211673723], [211674295, 211674513], [211675383, 211675630]], "strand": -1, "transcript": "NM_001204182", "txend": 211675630, "txstart": 211658256}, {"cdsend": 211675479, "cdsstart": 211667061, "chr": "1", "position": [[211666430, 211667231], [211669112, 211669332], [211670280, 211670407], [211671201, 211671284], [211673482, 211673723], [211674295, 211674513], [211675383, 211675630]], "strand": -1, "transcript": "NM_001204183", "txend": 211675630, "txstart": 211666430}, {"cdsend": 211675479, "cdsstart": 211663425, "chr": "1", "position": [[211662771, 211663652], [211667105, 211667231], [211669112, 211669332], [211670280, 211670407], [211671201, 211671284], [211673482, 211673723], [211674295, 211674513], [211675383, 211675621]], "strand": -1, "transcript": "NM_002497", "txend": 211675621, "txstart": 211662771}], "exons_hg19": [{"cdsend": 211848821, "cdsstart": 211831998, "chr": "1", "position": [[211831598, 211832054], [211840447, 211840573], [211842454, 211842674], [211843622, 211843749], [211844543, 211844626], [211846824, 211847065], [211847637, 211847855], [211848725, 211848972]], "strand": -1, "transcript": "NM_001204182", "txend": 211848972, "txstart": 211831598}, {"cdsend": 211848821, "cdsstart": 211840403, "chr": "1", "position": [[211839772, 211840573], [211842454, 211842674], [211843622, 211843749], [211844543, 211844626], [211846824, 211847065], [211847637, 211847855], [211848725, 211848972]], "strand": -1, "transcript": "NM_001204183", "txend": 211848972, "txstart": 211839772}, {"cdsend": 211848821, "cdsstart": 211836767, "chr": "1", "position": [[211836113, 211836994], [211840447, 211840573], [211842454, 211842674], [211843622, 211843749], [211844543, 211844626], [211846824, 211847065], [211847637, 211847855], [211848725, 211848963]], "strand": -1, "transcript": "NM_002497", "txend": 211848963, "txstart": 211836113}], "generif": [{"pubmed": 12221103, "text": "Nek2.PP1C complex is regulated by Inh2 via inhibition of phosphatase activity to initiate centrosome separation"}, {"pubmed": 12386167, "text": "cell cycle-regulated serine phosphorylation of Hec1 by Nek2 is essential for faithful chromosome segregation"}, {"pubmed": 12857871, "text": "Nek2A function is required for the correct execution of mitosis"}, {"pubmed": 14978040, "text": "NEK2A is a kinetochore-associated protein kinase essential for faithful chromosome segregation"}, {"pubmed": 15161910, "text": "Nucleolar Nek11 is a novel target of Nek2A in G1/S-arrested cells"}, {"pubmed": 15387139, "text": "Nek2 is involved in activation of the G2 checkpoint and is not secondary to cell cycle arrest"}, {"pubmed": 15492258, "text": "Nek2 protein is significantly up-regulated in preinvasive in situ ductal carcinomas of the breast as well as in invasive breast carcinomas."}, {"pubmed": 15659651, "text": "multiple processes involved in regulating the abundance of Nek2 kinase at the centrosome including microtubule binding, the centriolar satellite component pericentriolar material 1, and localized protein degradation"}, {"pubmed": 15950749, "text": "Down-regulation of NEK2A does not lead to mitotic defects; absence of the isozyme NK2B, a splice variant, leads to a mitotic delay and the formation of multinucleated cells."}, {"pubmed": 16084011, "text": "summary of the expression, regulation and function of Nek2 and its roles in human cancer [review]"}, {"pubmed": 16157594, "text": "DNA damage-induced inhibition of Plk1 leads to inhibition of Nek2 activity and thus prevents centrosome separation"}, {"pubmed": 17197699, "text": "Mutational analysis of autophosphorylation sites identified by mass spectrometry and x-ray structure show a complex pattern of positive and negative regulatory effects on kinase activity correlated with effects on centrosomal splitting efficiency"}, {"pubmed": 17283141, "text": "Radiation-induced inhibition of centrosome splitting was abrogated in cells expressing Nek2 mutated in the PP1-binding motif outside the kinase domain."}, {"pubmed": 17535851, "text": "Results report that NIP2, previously identified as centrobin, is a novel substrate of Nek2, and that NIP2 has a role in stabilizing the microtubule structure."}, {"pubmed": 17621308, "text": "Results suggest that NEK2A-mediated phosphorylation of Sgo1 (SGOL1) provides a link between centromeric cohesion and spindle microtubule attachment at the kinetochores."}, {"pubmed": 17626005, "text": "alternative splicing provides an unusual mechanism for modulating Nek2 localization, enabling it to have both nuclear and cytoplasmic functions."}, {"pubmed": 18086858, "text": "Nek2 binds and phosphorylates beta-catenin."}, {"pubmed": 18297113, "text": "that Hec1 binds to microtubule in low affinity and phosphorylation by NEK2A, which prevents aberrant kinetochore-microtubule connections in vivo, increases the affinity of the Ndc80 complex for microtubules in vitro"}, {"pubmed": 19008095, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19038001, "text": "Nek2 plays a critical role in carcinogenesis, tumor invasion, and tumorigenic growth of breast carcinoma."}, {"pubmed": 19123481, "text": "NEK2 overexpression is associated with papillary renal cell tumors with chromosome 1q duplication."}, {"pubmed": 20508983, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20581865, "text": "Abolishing the expression of cyclin D1, Cdk4 or Nek2 in MCF10A human mammary epithelial cells expressing H-Ras(G12V) abrogated Ras-induced centrosome amplification."}, {"pubmed": 20599736, "text": "these results suggest that kendrin anchors Nek2A and suppresses its kinase activity at the centrosomes, and thus, is involved in the mechanism to prevent premature centrosome splitting during interphase."}, {"pubmed": 20718755, "text": "Data show that although NEK2 was not universally recognized, it may serve as a tumor antigen for some patients."}, {"pubmed": 20734064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21076410, "text": "Study reports that two Hippo pathway components, Mst2 and the scaffold protein Salvador (hSav1), directly interact with Nek2A and regulate its ability to localize to centrosomes, and phosphorylate C-Nap1 and rootletin."}, {"pubmed": 21669869, "text": "leucine zipper of Nek2 kinase is the first example where the frameshift of coiled-coil heptad repeats has been directly observed experimentally"}, {"pubmed": 21723128, "text": "The counteracting Nek2A and PP1gamma activities on the centrosome linker are controlled by Plk1."}, {"pubmed": 21832156, "text": "Hec1 serine 165 (S165) is preferentially phosphorylated at kinetochores by Nek2 and it serves as an important mechanism in modulating spindle assemble checkpoint signaling and chromosome alignment."}, {"pubmed": 22014044, "text": "This study suggests that abnormal expression of Nek2 and beta-catenin might be one of the mechanisms of tumorigenesis in breast cancer"}, {"pubmed": 22234886, "text": "Nek2A might bear a close relationship with development and progression of breast carcinoma, and have a role as a potential biomarker for diagnosis and a possible therapeutic target for human breast cancer especially for breast ductal carcinoma in situ."}, {"pubmed": 22613497, "text": "The recruitment of Nek2 to the proximal ends of centrioles is dependent on one of its substrates, the centrosome cohesion protein C-Nap1."}, {"pubmed": 22824957, "text": "Nek2 C downregulation, using RNA interference, decreased the survival, invasion and migration of MCF10DCIS.com and MCF10CA1a cells as well as in human primary breast cancer tissue."}, {"pubmed": 22879911, "text": "Measuring IGF2BP3, HOXB7 and NEK2 mRNA levels by RT-PCR in addition to cytology has the potential to improve detection of malignant biliary disorders from brush cytology specimens."}, {"pubmed": 23001753, "text": "Our results indicate that genetic polymorphisms of centrobin and Nek2 are related to breast cancer susceptibility in Chinese Han women."}, {"pubmed": 23288039, "text": "Nek2A binds with high affinity to apo-APC/C and is degraded by the pool of Cdc20 that avoids inhibition by the spindle assembly checkpoint."}, {"pubmed": 23291182, "text": "NEK2 phosphorylation antagonizes the microtubule stabilizing activity of centrobin."}, {"pubmed": 23340795, "text": "small interfering RNA and antisense oligonucleotides against Nek2 worked synergistically with paclitaxel and doxorubicin by promoting cell apoptosis."}, {"pubmed": 23370767, "text": "These results suggest that the malignant transformation of plexiform neurofibroma is associated with distinct changes in the expression of BUB1B, PBK and NEK2"}, {"pubmed": 23708664, "text": "these data indicate that Nek2 has a pivotal role in breast cancer growth at primary and secondary sites, and thus may be an attractive and novel therapeutic target for this disease."}, {"pubmed": 23776583, "text": "Data conclude that centrosome amplification is modulated through Cdk4 and Nek2 signaling and that binucleation is a likely source of CA in Her2+ breast cancer cells."}, {"pubmed": 24043777, "text": "Whole genome sequencing in patients with retinitis pigmentosa reveals pathogenic DNA structural changes and NEK2 as a new disease gene."}, {"pubmed": 24046120, "text": "Up-regulation of NEK2 by microRNA-128 methylation is associated with colorectal cancer."}, {"pubmed": 24091727, "text": "Nek2 overexpression could not induce centrosome amplification and chromosome instability without expression of TRF1."}, {"pubmed": 24163369, "text": "NEK2 as a novel p53-repressed gene"}, {"pubmed": 24214971, "text": "CIP2A strongly interacts with NEK2 during G2/M phase, thereby enhancing NEK2 kinase activity to facilitate centrosome separation in a PP1- and PP2A-independent manner."}, {"pubmed": 24337664, "text": "NEK2 directly or indirectly interacts with a number of genes, proteins, microRNAs and biological processes associated with drug resistance in ovarian and other types of cancer."}, {"pubmed": 24389189, "text": "it appears that Nek2 and Plk4 might synergize to promote breast tumorigenesis and may also be involved in tamoxifen and trastuzumab resistance"}, {"pubmed": 24501426, "text": "These results identify a novel mechanism for regulating beta-catenin stability that is independent of GSK3beta and provide new insight into a pathway involving Plk1, Nek2, and beta-catenin that regulates the centrosome cycle."}, {"pubmed": 24763826, "text": "Nek2 may represent a new potential target for non-small cell lung cancer therapeutic intervention"}, {"pubmed": 24797070, "text": "Data suggest a role for Nek2 driving centrosome amplification downstream of the E2F3 activator."}, {"pubmed": 24966957, "text": "High expression of Nek2 could serve as an independent predictor of poor prognosis in pancreatic ductal adenocarcinoma."}, {"pubmed": 25043295, "text": "Overexpression of the Nek2 kinase is associated with colorectal cancer."}, {"pubmed": 25230277, "text": "Findings are consistent with the hypothesis that NEK2 contributes to ALDH1A1-dependent drug resistance in myeloma"}, {"pubmed": 25313354, "text": "Nek2 plays a central role in proteasome-mediated cell cycle regulation and in conferring resistance to bortezomib in cancer cells."}, {"pubmed": 25673878, "text": "Nek2A is degraded in mitosis regardless of enforced spindle checkpoint activation"}, {"pubmed": 25704143, "text": "Nek2 was demonstrated to phosphorylate Cep68 in vivo and this phosphorylation appears to promote Cep68 degradation in mitosis."}, {"pubmed": 25705694, "text": "we highlight recent findings on the aberrant expression and functional significance of NEK2A in human cancers and emphasize their significance for therapeutic potentials."}, {"pubmed": 26220856, "text": "Cep85 is a bona fide Nek2A-binding partner that surrounds the proximal ends of centrioles where it cooperates with PP1gamma (also known as PPP1CC) to antagonize Nek2A"}, {"pubmed": 26290419, "text": "Kif24 is a physiological substrate of Nek2, which regulates cilia disassembly through a concerted mechanism involving Kif24-mediated microtubule depolymerization."}, {"pubmed": 26320076, "text": "The results suggest that overexpression of NEK2 has the potential to serve as a biomarker for PCa prognosis."}, {"pubmed": 26337275, "text": "Our findings demonstrated that NEK2 could be a valuable carcinogenic factor and a promising therapeutic target for primary liver cancer"}, {"pubmed": 26823916, "text": "Suggest elevated Nek2 protein expression may be an independent risk factor for colon cancer."}, {"pubmed": 26851035, "text": "Hepatocellular carcinoma patients with high NEK2 expression had significantly poor recurrence-free survival (p=0.042) and early recurrence after hepatectomy."}, {"pubmed": 27019372, "text": "the functional roles of NEK2 in cancer development (review)"}, {"pubmed": 27108190, "text": "This study reports a novel set of Dengue virus (DENV) NS1-interacting host cell proteins in the HepG2 cell line and proposes possible roles for human NEK2, TAO1, and COG1 in DENV infection."}, {"pubmed": 27297360, "text": "Nek2A is found to stabilize SuFu at least partly depending on its kinase activity, thereby triggering phosphorylation of the SuFu protein."}, {"pubmed": 27349376, "text": "NEK2 was associated with unfavorable outcomes in HCC patients."}, {"pubmed": 27486244, "text": "Displacement of Dishevelled (DVL) from the centrosome and its release into the cytoplasm on NEK2 phosphorylation is coupled to the removal of linker proteins."}, {"pubmed": 27509921, "text": "enhanced NEK2 expression in hepatocellular carcinoma (HCC) promotes HCC progression and drug resistance by promoting PP1/Akt and Wnt pathway activation, which may represent a new therapeutic target for HCC."}, {"pubmed": 27925179, "text": "NEK2 modulates hepatoma cell functions, including growth, drug resistance, metastasis and angiogenesis via downstream genes activation"}, {"pubmed": 28086949, "text": "NEK2 promotes aerobic glycolysis through regulating splicing of PKM and increasing the PKM2/PKM1 ratio in myeloma cells which contributes to its oncogenic activity."}, {"pubmed": 28101574, "text": "Alteration of NEK2 protein levels may contribute to invasion and metastasis of hepatocellular carcinoma"}, {"pubmed": 28321704, "text": "present study firstly reveals that NEK2 protein is widely overexpressed in gliomas. NEK2 overexpression correlates significantly with malignancy (WHO grades), proliferation (Ki-67) and prognosis in malignant gliomas"}, {"pubmed": 28400617, "text": "evaluated the role of NEK2 in bone destruction of MM via clinical gene expression profiling data analysis and in vitro and in vivo mouse models. Further, treatment with the heparanase inhibitor Roneparstat, a Phase 1 drug in MM treatment,14 markedly inhibited OCL differentiation and rescued bone mass loss induced by NEK2 overexpression, suggesting that targeting NEK2 and/or its signaling pathway may be not only for preven"}, {"pubmed": 28475000, "text": "Our findings suggested that NIMA-related kinase 2B could play a role in the development and progression of breast cancer. Combination treatment using NIMA-related kinase 2B small interfering RNA and paclitaxel might be a novel potential therapy method for breast cancer."}, {"pubmed": 28514100, "text": "Results found NEK2 to be upregulated in lung cancer tissues and, its 3'-UTR mRNA is directly targeted by miR-128 to regulate its protein expression."}, {"pubmed": 28759960, "text": "Data suggest that low NIMA-related kinase 2 (NEK2) expression might be a useful predictor in hepatocellular carcinoma (HCC) as a poor prognostic factor, and could serve as a potential therapeutic target for HCC."}, {"pubmed": 28808310, "text": "Elevated NEK2, DLGAP5 and ECT2 expression was negatively correlated with both overall survival (OS) and relapse-free survival (RFS)."}, {"pubmed": 29141582, "text": "Nek2 is able to individually shorten cilia when cilia are growing but requires interaction with Aurora A when cilia are being absorbed. PP1 binding protein, PPP1R42, directly inhibits Nek2 and increases cilia formation."}, {"pubmed": 29225051, "text": "Taken together with the result that gamma-taxilin protein expression levels were decreased at the onset of mitosis, we propose that gamma-taxilin participates in Nek2A-mediated centrosome disjunction as a negative regulator through its interaction with Nek2A."}, {"pubmed": 29330624, "text": "We identified 16 potentially druggable candidates. Among them, NEK2, BIRC5, and TOP2A were also found to be amplified in breast cancer, suggesting that they could act as strategic players in the obese-deregulated transcriptome."}, {"pubmed": 29399700, "text": "NEK2 can promote HCC metastasis through induction of the epithelial-mesenchymal transition."}, {"pubmed": 29863498, "text": "Newly diagnosed myeloma patients with activated NF-kappaB signaling through increased NEK2 activity had poorer event-free and overall survivals based on multiple independent clinical cohorts."}, {"pubmed": 29949142, "text": "Loss of p53 was associated with increased NEK2 expression"}, {"pubmed": 30145571, "text": "NEK2 plays a significant role in cell cycle progression in hepatocellular carcinoma, promotes metastasis and is associated with high recurrence risk after hepatectomy."}, {"pubmed": 30295336, "text": "increased expression of NEK2 protein could not be predicted for poor survival but used as a novel biomarker for recurrence of NPC. Targeting NEK2 has the potential to eradicate the cisplatin-based chemotherapy resistant NPC cells."}, {"pubmed": 30417526, "text": "CircPDSS1 acts as a tumor promoter by regulating miR-186-5p and NEK2."}, {"pubmed": 30562736, "text": "High NEK2 expression is a risk factor for poor survival in Hepatocellular Carcinoma patients."}, {"pubmed": 30575919, "text": "Expression level of miR-128 in glioma tissues was significantly lower and NEK2 expression level was higher than that of normal brain tissues. MiR-128 expression was correlated to tumor size and malignant level of glioma, whereas not related to age and gender of glioma patients. Dual-luciferase reporter gene assay indicated that miR-128 directly bound to NEK2."}, {"pubmed": 30707691, "text": "Controlling the dynamics of the Nek2 leucine zipper by engineering of \"kinetic\" disulphide bonds."}, {"pubmed": 30720160, "text": "The miR-1299 was a novel suppressor in prostate cancers (PCa) through its negative regulation of NEK2."}, {"pubmed": 30968157, "text": "Study provide new evidence to suggest that CUG2 overexpression contributes to tumor formation through NEK2/beta-catenin signaling by enhancing the phosphorylation of betacatenin at Ser33/Ser37 by activating NEK2, thus stabilizing betacatenin."}, {"pubmed": 31174562, "text": "Our study suggested that Nek2B can bind to beta-catenin and the co-expression correlated with TNBC patients poor prognosis. It appears that Nek2B and beta-catenin might synergize to promote chemotherapy resistance."}, {"pubmed": 31249448, "text": "NEK2 was significantly up-regulated in human gastric cancer (GC) tissues. ERK was significantly associated with NEK2 expression in human clinical specimens, and combined overexpression of NEK2 and ERK potentially forecasted a poor prognosis and survival in GC patients."}, {"pubmed": 31319849, "text": "Data found that Nek2 could bind beta-catenin in sorafenib-treated hepatocellular carcinoma (HCC) cell lines. Nek2 stabilizes beta-catenin and promotes its translocation to the nucleus, consequently activating the transcription of downstream target genes. Also, further results confirmed that Nek2 could induce sorafenib resistance in HCC cell lines"}, {"pubmed": 31460782, "text": "Integrative Bioinformatics Analysis Identifies NEK2 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma."}, {"pubmed": 31646554, "text": "PCAT1 promotes the proliferative and migratory potentials of ovarian cancer via targeting NEK2."}, {"pubmed": 31906878, "text": "the NEK protein kinases emerge as important proteins in thyroid cancer development and may help to identify malignancy and aggressiveness features during diagnosis."}, {"pubmed": 32033228, "text": "Bioinformatics Analysis of Global Proteomic and Phosphoproteomic Data Sets Revealed Activation of NEK2 and AURKA in Cancers."}, {"pubmed": 32054769, "text": "LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance."}, {"pubmed": 32211891, "text": "Nek2 kinase displaces distal appendages from the mother centriole prior to mitosis."}, {"pubmed": 32289147, "text": "Nek2-mediated GAS2L1 phosphorylation and centrosome-linker disassembly induce centrosome disjunction."}, {"pubmed": 32504181, "text": "High Expression of NEK2 and PIM1, but Not PIM3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine Neoplasms."}, {"pubmed": 32558224, "text": "microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2."}, {"pubmed": 32761510, "text": "High expression of NEK2 promotes lung cancer progression and drug resistance and is regulated by mutant EGFR."}, {"pubmed": 32907622, "text": "Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1/beta-catenin signaling pathway in cervical cancer."}, {"pubmed": 33109182, "text": "Involvement of NEK2 and its interaction with NDC80 and CEP250 in hepatocellular carcinoma."}, {"pubmed": 33201407, "text": "High expression of NEK2 promotes gastric cancer progression via activating AKT signaling."}, {"pubmed": 33267874, "text": "Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells."}, {"pubmed": 33907253, "text": "The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells."}, {"pubmed": 34009515, "text": "Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling."}, {"pubmed": 34315872, "text": "NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1."}, {"pubmed": 34850664, "text": "ETV4 mediated lncRNA C2CD4D-AS1 overexpression contributes to the malignant phenotype of lung adenocarcinoma cells via miR-3681-3p/NEK2 axis."}, {"pubmed": 35031599, "text": "NEK2 enhances malignancies of glioblastoma via NIK/NF-kappaB pathway."}, {"pubmed": 35088582, "text": "Genetic Aberrations and Interaction of NEK2 and TP53 Accelerate Aggressiveness of Multiple Myeloma."}, {"pubmed": 35338518, "text": "Role of NIMA-related kinase 2 in lung cancer: Mechanisms and therapeutic prospects."}, {"pubmed": 35545405, "text": "NEK2 promotes the progression of liver cancer by resisting the cellular senescence.\", trans \"NEK2."}, {"pubmed": 35705994, "text": "NEK2 promotes the migration and proliferation of ESCC via stabilization of YAP1 by phosphorylation at Thr-143."}, {"pubmed": 36115593, "text": "NEK2 inactivates the Hippo pathway to advance the proliferation of cervical cancer cells by cooperating with STRIPAK complexes."}, {"pubmed": 36370999, "text": "NEK2 is associated with poor prognosis of clear cell renal cell carcinoma and promotes tumor cell growth and metastasis."}, {"pubmed": 36738674, "text": "Molecular characteristics, oncogenic roles, and relevant immune and pharmacogenomic features of NEK2 in gastric cancer."}, {"pubmed": 38182898, "text": "Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers."}, {"pubmed": 38493150, "text": "Nek2A prevents centrosome clustering and induces cell death in cancer cells via KIF2C interaction."}, {"pubmed": 38494974, "text": "[Expression and clinical significance of NEK2 and EMT related molecules in oral squamous cell carcinoma]."}, {"pubmed": 38721812, "text": "Abnormal methylation mediated upregulation of LINC00857 boosts malignant progression of lung adenocarcinoma by modulating the miR-486-5p/NEK2 axis."}, {"pubmed": 38758909, "text": "Function of NEK2 in clear cell renal cell carcinoma and its effect on the tumor microenvironment."}, {"pubmed": 38764296, "text": "NEK2 promotes TP53 ubiquitination to enhance the proliferation and migration of TP53 wild-type glioblastoma cells."}, {"pubmed": 38795132, "text": "NEK2 promotes the development of ovarian endometriosis and impairs decidualization by phosphorylating FOXO1."}], "genomic_pos": {"chr": "1", "end": 211675630, "ensemblgene": "ENSG00000117650", "start": 211658657, "strand": -1}, "genomic_pos_hg19": {"chr": "1", "end": 211848960, "start": 211836114, "strand": -1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0000278", "pubmed": 9430639, "qualifier": "involved_in", "term": "mitotic cell cycle"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001824", "qualifier": "involved_in", "term": "blastocyst development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006468", "pubmed": 21076410, "qualifier": "involved_in", "term": "protein phosphorylation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006468", "pubmed": 24554434, "qualifier": "involved_in", "term": "protein phosphorylation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007059", "qualifier": "involved_in", "term": "chromosome segregation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0007059", "pubmed": 14978040, "qualifier": "involved_in", "term": "chromosome segregation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007088", "pubmed": 9430639, "qualifier": "involved_in", "term": "regulation of mitotic nuclear division"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032212", "pubmed": 21531765, "qualifier": "involved_in", "term": "positive regulation of telomere maintenance via telomerase"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0046602", "pubmed": 26220856, "qualifier": "involved_in", "term": "regulation of mitotic centrosome separation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0046602", "pubmed": 16280549, "qualifier": "involved_in", "term": "regulation of mitotic centrosome separation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0046777", "pubmed": 17626005, "qualifier": "involved_in", "term": "protein autophosphorylation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0046777", "pubmed": 10880350, "qualifier": "involved_in", "term": "protein autophosphorylation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0051225", "pubmed": 16280549, "qualifier": "involved_in", "term": "spindle assembly"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0051299", "pubmed": 18086858, "qualifier": "involved_in", "term": "centrosome separation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051301", "qualifier": "involved_in", "term": "cell division"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051321", "qualifier": "involved_in", "term": "meiotic cell cycle"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0051973", "pubmed": 21531765, "qualifier": "involved_in", "term": "positive regulation of telomerase activity"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0051988", "pubmed": 18297113, "qualifier": "involved_in", "term": "regulation of attachment of spindle microtubules to kinetochore"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0090307", "qualifier": "involved_in", "term": "mitotic spindle assembly"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1903126", "pubmed": 24554434, "qualifier": "involved_in", "term": "negative regulation of centriole-centriole cohesion"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1904355", "pubmed": 21531765, "qualifier": "involved_in", "term": "positive regulation of telomere capping"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0000776", "pubmed": 17621308, "qualifier": "colocalizes_with", "term": "kinetochore"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0000776", "pubmed": 14978040, "qualifier": "located_in", "term": "kinetochore"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0000794", "qualifier": "located_in", "term": "condensed nuclear chromosome"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0000922", "qualifier": "located_in", "term": "spindle pole"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005730", "qualifier": "located_in", "term": "nucleolus"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005813", "qualifier": "is_active_in", "term": "centrosome"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005813", "pubmed": [21399614, 26220856], "qualifier": "located_in", "term": "centrosome"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005874", "qualifier": "located_in", "term": "microtubule"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0030496", "qualifier": "located_in", "term": "midbody"}, {"evidence": "IMP", "gocategory": "CC", "id": "GO:0032991", "pubmed": 10880350, "qualifier": "part_of", "term": "protein-containing complex"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0004672", "pubmed": [10880350, 18086858, 26220856], "qualifier": "enables", "term": "protein kinase activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0004672", "pubmed": 24554434, "qualifier": "enables", "term": "protein kinase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004674", "qualifier": "enables", "term": "protein serine/threonine kinase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0004674", "pubmed": 16280549, "qualifier": "enables", "term": "protein serine/threonine kinase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [9647649, 10880350, 14978040, 15161910, 16648845, 17621308, 18086858, 21382349, 23288039, 24116158, 24554434, 26220856, 26290419, 30404835], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005524", "qualifier": "enables", "term": "ATP binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019903", "pubmed": 10880350, "qualifier": "enables", "term": "protein phosphatase binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0106310", "qualifier": "enables", "term": "protein serine kinase activity"}]}, "homologene": {"genes": [[4896, 2542237], [7955, 394025], [8364, 100328980], [9031, 421376], [9544, 711473], [9598, 457714], [9606, 4751], [9615, 480021], [9913, 523998], [10090, 18005]], "id": 74441}, "interpro": [{"desc": "Protein kinase domain", "id": "IPR000719", "short_desc": "Prot_kinase_dom"}, {"desc": "Serine/threonine-protein kinase, active site", "id": "IPR008271", "short_desc": "Ser/Thr_kinase_AS"}, {"desc": "Protein kinase-like domain superfamily", "id": "IPR011009", "short_desc": "Kinase-like_dom_sf"}], "ipi": ["IPI00021331", "IPI00641713", "IPI00647904", "IPI01014791", "IPI01025730"], "map_location": "1q32.3", "name": "NIMA related kinase 2", "other_names": ["NIMA (never in mitosis gene a)-related kinase 2", "nimA-like protein kinase 1", "nimA-related protein kinase 2", "protein phosphatase 1, regulatory subunit 111", "serine/threonine-protein kinase Nek2"], "pantherdb": {"HGNC": "7745", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "109359", "ortholog_type": "LDO", "panther_family": "PTHR43671", "taxid": 10090, "uniprot_kb": "O35942"}, {"RGD": "1582899", "ortholog_type": "LDO", "panther_family": "PTHR43671", "taxid": 10116, "uniprot_kb": "G3V6L2"}, {"Ensembl": "ENSGALG00000009854", "ortholog_type": "LDO", "panther_family": "PTHR43671", "taxid": 9031, "uniprot_kb": "F1NI69"}, {"ZFIN": "ZDB-GENE-040426-752", "ortholog_type": "LDO", "panther_family": "PTHR43671", "taxid": 7955, "uniprot_kb": "Q7ZUN2"}, {"FlyBase": "FBgn0029970", "ortholog_type": "LDO", "panther_family": "PTHR43671", "taxid": 7227, "uniprot_kb": "Q9W3N8"}, {"SGD": "S000003284", "ortholog_type": "O", "panther_family": "PTHR43671", "taxid": 4932, "uniprot_kb": "P53233"}, {"SGD": "S000000071", "ortholog_type": "LDO", "panther_family": "PTHR43671", "taxid": 4932, "uniprot_kb": "P22209"}, {"PomBase": "SPAC19E9.02", "ortholog_type": "LDO", "panther_family": "PTHR43671", "taxid": 4896, "uniprot_kb": "O13839"}, {"dictyBase": "DDB_G0270814", "ortholog_type": "LDO", "panther_family": "PTHR43671", "taxid": 352472, "uniprot_kb": "Q55BN8"}], "uniprot_kb": "P51955"}, "pathway": {"pid": {"id": "foxm1pathway", "name": "FOXM1 transcription factor network"}, "reactome": [{"id": "R-HSA-1640170", "name": "Cell Cycle"}, {"id": "R-HSA-174143", "name": "APC/C-mediated degradation of cell cycle proteins"}, {"id": "R-HSA-176409", "name": "APC/C:Cdc20 mediated degradation of mitotic proteins"}, {"id": "R-HSA-176814", "name": "Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins"}, {"id": "R-HSA-179409", "name": "APC-Cdc20 mediated degradation of Nek2A"}, {"id": "R-HSA-179419", "name": "APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint"}, {"id": "R-HSA-1852241", "name": "Organelle biogenesis and maintenance"}, {"id": "R-HSA-2565942", "name": "Regulation of PLK1 Activity at G2/M Transition"}, {"id": "R-HSA-380259", "name": "Loss of Nlp from mitotic centrosomes"}, {"id": "R-HSA-380270", "name": "Recruitment of mitotic centrosome proteins and complexes"}, {"id": "R-HSA-380284", "name": "Loss of proteins required for interphase microtubule organization from the centrosome"}, {"id": "R-HSA-380287", "name": "Centrosome maturation"}, {"id": "R-HSA-380320", "name": "Recruitment of NuMA to mitotic centrosomes"}, {"id": "R-HSA-453274", "name": "Mitotic G2-G2/M phases"}, {"id": "R-HSA-453276", "name": "Regulation of mitotic cell cycle"}, {"id": "R-HSA-5617833", "name": "Cilium Assembly"}, {"id": "R-HSA-5620912", "name": "Anchoring of the basal body to the plasma membrane"}, {"id": "R-HSA-68877", "name": "Mitotic Prometaphase"}, {"id": "R-HSA-68886", "name": "M Phase"}, {"id": "R-HSA-69275", "name": "G2/M Transition"}, {"id": "R-HSA-69278", "name": "Cell Cycle, Mitotic"}, {"id": "R-HSA-8854518", "name": "AURKA Activation by TPX2"}], "wikipathways": {"id": "WP4803", "name": "Ciliopathies"}}, "pdb": ["2JAV", "2W5A", "2W5B", "2W5H", "2WQO", "2XK3", "2XK4", "2XK6", "2XK7", "2XK8", "2XKC", "2XKD", "2XKE", "2XKF", "2XNM", "2XNN", "2XNO", "2XNP", "4A4X", "4AFE", "5M51", "5M53", "5M55", "5M57", "6SGD", "6SGH", "6SGI", "6SGK", "6SK9", "6TM5"], "pfam": "PF00069", "pharmgkb": "PA31546", "pharos": {"target_id": 9217, "tdl": "Tchem"}, "pir": ["G01452", "I38215"], "prosite": "PS50011", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF253183", "relationship": "is"}, {"id": "GNF253184", "relationship": "is"}, {"id": "GNF253185", "relationship": "is"}, {"id": "GNF253186", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF037855", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF086585", "relationship": "is"}, {"id": "GNF086586", "relationship": "is"}, {"id": "GNF086587", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF050588", "relationship": "is"}, {"id": "GNF055351", "relationship": "is"}, {"id": "GNF059973", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF066295", "relationship": "is"}, {"id": "GNF066296", "relationship": "is"}], "GNF_hs-pkinase_IDT-siRNA": [{"id": "GNF165320", "relationship": "is"}, {"id": "GNF165321", "relationship": "is"}, {"id": "GNF165322", "relationship": "is"}, {"id": "GNF165323", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF010256", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF239277", "relationship": "is"}, "Invitrogen_IVTHSSIPKv2": [{"id": "GNF323890", "relationship": "is"}, {"id": "GNF323891", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF335127", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF092718", "relationship": "is"}, {"id": "GNF132416", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_029112.1"], "protein": ["NP_001191111.1", "NP_001191112.1", "NP_002488.1"], "rna": ["NM_001204182.2", "NM_001204183.2", "NM_002497.4"], "translation": [{"protein": "NP_001191111.1", "rna": "NM_001204182.2"}, {"protein": "NP_001191112.1", "rna": "NM_001204183.2"}, {"protein": "NP_002488.1", "rna": "NM_002497.4"}]}, "reporter": {"HG-U133_Plus_2": ["204641_at", "211080_s_at"], "HG-U95Av2": "366_s_at", "HTA-2_0": ["TC01003798.hg.1", "TC01006091.hg.1"], "HuEx-1_0": ["2454444", "3527039"], "HuGene-1_1": "7924096", "HuGene-2_1": "16698984"}, "summary": "This gene encodes a serine/threonine-protein kinase that is involved in mitotic regulation. This protein is localized to the centrosome, and undetectable during G1 phase, but accumulates progressively throughout the S phase, reaching maximal levels in late G2 phase. Alternatively spliced transcript variants encoding different isoforms with distinct C-termini have been noted for this gene. [provided by RefSeq, Feb 2011].", "symbol": "NEK2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1417672"}, "unigene": "Hs.153704", "uniprot": {"Swiss-Prot": "P51955", "TrEMBL": "F6U4U2"}, "wikipedia": {"url_stub": "NEK2"}}